Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

759 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission.
Permar SR, Fong Y, Vandergrift N, Fouda GG, Gilbert P, Parks R, Jaeger FH, Pollara J, Martelli A, Liebl BE, Lloyd K, Yates NL, Overman RG, Shen X, Whitaker K, Chen H, Pritchett J, Solomon E, Friberg E, Marshall DJ, Whitesides JF, Gurley TC, Von Holle T, Martinez DR, Cai F, Kumar A, Xia SM, Lu X, Louzao R, Wilkes S, Datta S, Sarzotti-Kelsoe M, Liao HX, Ferrari G, Alam SM, Montefiori DC, Denny TN, Moody MA, Tomaras GD, Gao F, Haynes BF. Permar SR, et al. Among authors: montefiori dc. J Clin Invest. 2015 Jul 1;125(7):2702-6. doi: 10.1172/JCI81593. Epub 2015 Jun 8. J Clin Invest. 2015. PMID: 26053661 Free PMC article. Clinical Trial.
V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
Montefiori DC, Graham BS, Zhou J, Zhou J, Bucco RA, Schwartz DH, Cavacini LA, Posner MR. Montefiori DC, et al. J Clin Invest. 1993 Aug;92(2):840-7. doi: 10.1172/JCI116658. J Clin Invest. 1993. PMID: 8349820 Free PMC article. Clinical Trial.
Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains.
Liao HX, Etemad-Moghadam B, Montefiori DC, Sun Y, Sodroski J, Scearce RM, Doms RW, Thomasch JR, Robinson S, Letvin NL, Haynes BF. Liao HX, et al. Among authors: montefiori dc. J Virol. 2000 Jan;74(1):254-63. doi: 10.1128/jvi.74.1.254-263.2000. J Virol. 2000. PMID: 10590113 Free PMC article.
Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope.
Letvin NL, Robinson S, Rohne D, Axthelm MK, Fanton JW, Bilska M, Palker TJ, Liao HX, Haynes BF, Montefiori DC. Letvin NL, et al. Among authors: montefiori dc. J Virol. 2001 May;75(9):4165-75. doi: 10.1128/JVI.75.9.4165-4175.2001. J Virol. 2001. PMID: 11287566 Free PMC article.
HIV vaccine development at Duke University Medical Center.
Haynes BF, Liao HX, Staats HF, Alam MS, Weinhold KJ, Montefiori DC. Haynes BF, et al. Among authors: montefiori dc. Immunol Res. 2000;22(2-3):263-9. doi: 10.1385/ir:22:2-3:263. Immunol Res. 2000. PMID: 11339361 Review.
759 results